Consumer acceptable risk: how cigarette companies have responded to accusations that their products are defective

被引:17
作者
Cummings, K. Michael
Brown, Anthony
Douglas, Clifford E.
机构
[1] Roswell Pk Canc Inst, Dept Hlth Behav, Div Canc Prevent & Populat Sci, Buffalo, NY 14263 USA
[2] Tobacco Control Law & Policy Consulting, Ann Arbor, MI USA
关键词
D O I
10.1136/tc.2004.009837
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: To describe arguments used by cigarette companies to defend themselves against charges that their cigarettes were defective and that they could and should have done more to make cigarettes less hazardous. Methods: The data for this paper come from the opening statements made by defendants in four court cases: two class action lawsuits (Engle 1999, and Blankenship 2001) and two individual cases (Boeken 2001, and Schwarz 2002). The transcripts of opening statements were reviewed and statements about product defect claims, product testing, and safe cigarette research were excerpted and coded. Results: Responses by cigarette companies to charges that their products were defective has been presented consistently across different cases and by different companies. Essentially the arguments made by cigarette companies boil down to three claims: (1) smoking is risky, but nothing the companies have done has made cigarettes more dangerous than might otherwise be the case; (2) nothing the companies have done or said has kept someone from stopping smoking; and (3) the companies have spent lots of money to make the safest cigarette acceptable to the smoker. Conclusions: Cigarette companies have argued that their products are inherently dangerous but not defective, and that they have worked hard to make their products safer by lowering the tar and nicotine content of cigarettes as recommended by members of the public health community. As a counter argument, plaintiff attorneys should focus on how cigarette design changes have actually made smoking more acceptable to smokers, thereby discouraging smoking cessation.
引用
收藏
页码:84 / 89
页数:6
相关论文
共 19 条
[1]  
[Anonymous], 1994, TOB CONTROL, V3, P362
[2]   Are smokers adequately informed about the health risks of smoking and medicinal nicotine? [J].
Cummings, KM ;
Hyland, A ;
Giovino, GA ;
Hastrup, JL ;
Bauer, JE ;
Bansal, MA .
NICOTINE & TOBACCO RESEARCH, 2004, 6 :333-340
[3]   Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking [J].
Cummings, KM ;
Morley, CP ;
Hyland, A .
TOBACCO CONTROL, 2002, 11 :I110-I117
[4]   Why tobacco litigation? [J].
Daynard, R .
TOBACCO CONTROL, 2003, 12 (01) :1-2
[5]  
Daynard R., 1994, TOB CONTROL, V3, P59
[6]   Taking aim at the bull's-eye: the nicotine in tobacco products [J].
Douglas, CE .
TOBACCO CONTROL, 1998, 7 (03) :215-218
[7]   Harm reduction: 25 years later [J].
Farone, WA .
TOBACCO CONTROL, 2002, 11 (04) :287-288
[8]   Consumers' knowledge and beliefs about the safety of cigarette filters [J].
Hastrup, JL ;
Cummings, KM ;
Swedrock, T ;
Hyland, A ;
Pauly, JL .
TOBACCO CONTROL, 2001, 10 (01) :84-84
[9]  
Henningfield JE, 2004, NICOTINE TOB RES, V6, P199
[10]   Does menthol enhance the addictiveness of cigarettes? An agenda for research [J].
Henningfield, JE ;
Benowitz, NL ;
Ahijevych, K ;
Garrett, BE ;
Connolly, GN ;
Wayne, GF .
NICOTINE & TOBACCO RESEARCH, 2003, 5 (01) :9-11